Glaukos to Outline Growth Strategy at Investor Day

by Business Wire • 2017/09/14 • 0 Comments

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, will provide an overview of its growth strategy and market opportunity, update progress of its innovative pipeline products and revise 2017 net sales guidance during its Investor Day meeting today in New York City. “As the founder and pioneer of M

← Researchers identify potential biomarkers of age-related macular degeneration

Patent granted for method of use of Acucela’s Stargardt disease treatment →

Post navigation